SB 216763 Gene Set
Genes
14 interacting proteins for the SB 216763 drug from theDGIdb Drug Targets 2026 dataset.
| Symbol |
Name |
Standardized Value |
|
GSK3B
|
glycogen synthase kinase 3 beta
|
0.24551
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
0.114571
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
0.105024
|
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4
|
0.0804438
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
0.0651872
|
|
PAX8
|
paired box 8
|
0.0572857
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
0.0211221
|
|
DRD1
|
dopamine receptor D1
|
0.0207739
|
|
USP1
|
ubiquitin specific peptidase 1
|
0.0177505
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
0.0103021
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
0.00867169
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
0.00792632
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
0.00647407
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
0.00426733
|